CONSULTANCY REPORTS
Evaluation of the National Consent
Swiss Biobanking Platform has been appointed by the Swiss Academy of Medical Sciences to evaluate the v1 / 2017 version of national consent. For this task, SBP has been supported by its Governance Advisory Board and has consulted several stakeholders, whose opinions have been considered essential, for a comprehensive and relevant evaluation. Among the consulted parties were:
- the five University Hospitals
- the Interface science-société – UNIL, Lausanne
- Patients’ organizations
- the supporting infrastructure for European biobanks, BBMRI
- the Federal Data Protection and Information Commissioner